Validation and Reliability Testing of the EORTC QLQ-NMIBC24 Questionnaire Module to Assess Patient-reported Outcomes in Non–Muscle-invasive Bladder Cancer-Reference-Cited by-同舟云学术

Validation and Reliability Testing of the EORTC QLQ-NMIBC24 Questionnaire Module to Assess Patient-reported Outcomes in Non–Muscle-invasive Bladder Cancer

Published:2014-12 Issue:6 Volume:66 Page:1148-1156
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Blazeby Jane M.,Hall Emma,Aaronson Neil K.,Lloyd Lisa,Waters Rachel,Kelly John D.,Fayers Peter

Publisher

Elsevier BV

Subject

Urology

Reference16 articles.

1. Bladder cancer incidence statistics. Cancer Research UK Web site. http://info.cancerresearchuk.org/cancerstats/types/bladder/incidence/. Accessed September 2013.

2. US Department of Health and Human Services, Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Accessed September 2013.

3. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology;Aaronson;J Natl Cancer Inst,1993

4. Manuals. European Organization for Research and Treatment of Cancer Web site. http://groups.eortc.be/qol/manuals. Accessed September 2013.

5. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure;Cella;J Clin Oncol,1993

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient experience and unmet needs in high-risk nonmuscle-invasive bladder cancer: Insights from qualitative interviews and a cross-sectional survey;Urologic Oncology: Seminars and Original Investigations;2024-01

2. Prognostic value of a panel of immunohistochemical markers for determining the risk of recurrence and progression of non-invasive bladder cancer;Український радіологічний та онкологічний журнал;2023-12-29

4. Wake-Up Call to Address Sleep Health in Non-Muscle Invasive Bladder Cancer: Underappreciated Contributor to Poor Quality of Life;Bladder Cancer;2023-12-13

5. Protocol of the Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) study: a pragmatic, prospective multicenter observational cohort study of recurrent high-grade non-muscle invasive bladder cancer;BMC Cancer;2023-11-18